Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000205628 | SCV000260488 | uncertain significance | Hereditary nonpolyposis colorectal neoplasms | 2019-11-03 | criteria provided, single submitter | clinical testing | This sequence change replaces serine with asparagine at codon 1279 of the MSH6 protein (p.Ser1279Asn). The serine residue is highly conserved and there is a small physicochemical difference between serine and asparagine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with MSH6-related disease. ClinVar contains an entry for this variant (Variation ID: 220159). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV000481950 | SCV000565236 | uncertain significance | not provided | 2017-05-31 | criteria provided, single submitter | clinical testing | This variant is denoted MSH6 c.3836G>A at the cDNA level, p.Ser1279Asn (S1279N) at the protein level, and results in the change of a Serine to an Asparagine (AGC>AAC). This variant has not, to our knowledge, been published in the literature as pathogenic or benign. MSH6 Ser1279Asn was not observed in large population cohorts (NHLBI Exome Sequencing Project, The 1000 Genomes Consortium 2015, Lek 2016). Since Serine and Asparagine share similar properties, this is considered a conservative amino acid substitution. MSH6 Ser1279Asn occurs at a position that is conserved across species and is located in the ATPase domain (Warren 2007, Kansikas 2011). In silico analyses are inconsistent regarding the effect this variant may have on protein structure and function. Based on currently available evidence, it is unclear whether MSH6 Ser1279Asn is a pathogenic or benign variant. We consider it to be a variant of uncertain significance. |
Ambry Genetics | RCV000562735 | SCV000662359 | uncertain significance | Hereditary cancer-predisposing syndrome | 2018-09-24 | criteria provided, single submitter | clinical testing | Insufficient or conflicting evidence |
Color | RCV000562735 | SCV000685449 | uncertain significance | Hereditary cancer-predisposing syndrome | 2020-02-13 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000662811 | SCV000785646 | uncertain significance | Hereditary nonpolyposis colorectal cancer type 5 | 2017-10-18 | criteria provided, single submitter | clinical testing |